We are live on ! Find out more
CSCI

COSCIENS Biopharma Inc. Common Stock
CSCI

Delisted

CSCI was delisted on the 3rd of September, 2025.

Back to rankings

2 hedge funds and large institutions have $10.3K invested in COSCIENS Biopharma Inc. Common Stock in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.73% less ownership

Funds ownership: 0.85% → 0.12% (-0.73%)

87% less funds holding

Funds holding: 15 → 2 (-13)

89% less capital invested

Capital invested by funds: $90.5K → $10.3K (-$80.2K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 13

Holders
2
Holders Change
-13
Holders Change %
-86.67%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$39K
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$14K
3
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$8.1K
4
UBS Group
UBS Group
Switzerland
-$8.05K
5
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$3.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
TWC
1
TD Waterhouse Canada
Ontario, Canada
$10.2K – – –
Osaic Holdings
2
Osaic Holdings
Arizona
$153 – – –
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
– -$39K -11,504 Closed
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
– -$14K -4,239 Closed
FDCDDQ
5
Federation des caisses Desjardins du Quebec
Quebec, Canada
– -$8.1K -2,435 Closed
UBS Group
6
UBS Group
Switzerland
– -$8.05K -2,369 Closed
National Bank of Canada
7
National Bank of Canada
Quebec, Canada
– -$3.8K -1,149 Closed
Morgan Stanley
8
Morgan Stanley
New York
– -$1.7K -500 Closed
MCM
9
MAI Capital Management
Ohio
– -$1.36K -401 Closed
SS
10
SBI Securities
Japan
– -$561 -165 Closed
BNP Paribas Financial Markets
11
BNP Paribas Financial Markets
France
– -$339 -100 Closed
Group One Trading
12
Group One Trading
Illinois
– -$125 -37 Closed
TC
13
Truvestments Capital
Florida
– -$75 -22 Closed
Raymond James Financial
14
Raymond James Financial
Florida
– -$7 -2 Closed
GLF
15
Groupe la Francaise
France
– -$3 -1 Closed

CSCI Hedge Fund Activity: Q3 2025 in Review

2 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in COSCIENS Biopharma Inc. Common Stock (CSCI) for Q3 2025, worth a combined $10.3K — down 89% from $90.5K a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of CSCI and 0 opened new positions — a net loss of 13 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Susquehanna International Group, exiting entirely with an estimated $39K sold.

  • 2 institutional investors held COSCIENS Biopharma Inc. Common Stock (CSCI) as of Q3 2025, down from 15 in Q2 2025.
  • Funds reported $10.3K of COSCIENS Biopharma Inc. Common Stock stock for Q3 2025, down 89% quarter-over-quarter.
  • 0 funds opened new COSCIENS Biopharma Inc. Common Stock positions in Q3 2025 and 13 closed out, a net change of -13 holders.
  • The largest COSCIENS Biopharma Inc. Common Stock seller in Q3 2025 was Susquehanna International Group, an estimated $39K sold.

Based on aggregated 13F filings for Q3 2025.